PMID-sentid Pub_year Sent_text comp_official_name comp_offsetprotein_name organism prot_offset 3546047-1 1986 The effect of cholinomimetic stimulation by infusion of edrophonium chloride or muscarinic blockade by infusion of atropine sulfate on insulin and GIP secretion was studied in normal lean subjects during eu- and hyperglycemia. Atropine 115-131 gastric inhibitory polypeptide Homo sapiens 147-150 3546047-4 1986 The effect of atropine infusion on fasting plasma insulin and GIP was subsequently studied in 11 obese patients and 10 lean subjects. Atropine 14-22 gastric inhibitory polypeptide Homo sapiens 62-65 3546047-5 1986 Muscarinic antagonism by atropine led to a transient non-significant suppression of GIP and insulin in lean subjects, but to a significant, sustained suppression of these hormones in obese patients. Atropine 25-33 gastric inhibitory polypeptide Homo sapiens 84-87 16435472-3 1981 On the day without atropine, plasma GIP and serum insulin increased significantly. Atropine 19-27 gastric inhibitory polypeptide Homo sapiens 36-39 3890140-0 1985 Effects of atropine on GIP-induced insulin and pancreatic polypeptide release in man. Atropine 11-19 gastric inhibitory polypeptide Homo sapiens 23-26 16435472-4 1981 The increases in plasma GIP and serum insulin were significantly attenuated by atropine. Atropine 79-87 gastric inhibitory polypeptide Homo sapiens 24-27 7031846-2 1981 This increase was significantly (p = 0.031) attenuated when atropine was given together with insulin, indicating that the vagal nerves play a major role in the release of plasma GIP during hypoglycemia. Atropine 60-68 gastric inhibitory polypeptide Homo sapiens 178-181 752033-5 1978 We conclude that: 1) the rise in serum gastrin adter a meal preceeds the rise in serum GIP; 2) atropine potentiates the late gastrin response while suppressing the increase in serum GIP after a meal; and 3) the mechanism by which atropine potentiates gastrin release may be related to its suppressive effects on intestinal inhibitors of gastrin secretion, such as GIP. Atropine 95-103 gastric inhibitory polypeptide Homo sapiens 182-185 752033-4 1978 The normal meal-stimulated rise in serum GIP was almost completely inhibited by atropine. Atropine 80-88 gastric inhibitory polypeptide Homo sapiens 41-44 752033-5 1978 We conclude that: 1) the rise in serum gastrin adter a meal preceeds the rise in serum GIP; 2) atropine potentiates the late gastrin response while suppressing the increase in serum GIP after a meal; and 3) the mechanism by which atropine potentiates gastrin release may be related to its suppressive effects on intestinal inhibitors of gastrin secretion, such as GIP. Atropine 95-103 gastric inhibitory polypeptide Homo sapiens 87-90 752033-5 1978 We conclude that: 1) the rise in serum gastrin adter a meal preceeds the rise in serum GIP; 2) atropine potentiates the late gastrin response while suppressing the increase in serum GIP after a meal; and 3) the mechanism by which atropine potentiates gastrin release may be related to its suppressive effects on intestinal inhibitors of gastrin secretion, such as GIP. Atropine 95-103 gastric inhibitory polypeptide Homo sapiens 182-185